Skip to main content
BSX
NYSE Industrial Applications And Services

Boston Scientific Prices $3.0B Four-Tranche Senior Notes to Fund Penumbra Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$43.07
Mkt Cap
$62.313B
52W Low
$39.57
52W High
$101.91
52W Position info
8.8% above low
Off High info
58% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $39.57 (8.8% above the low).

Summary

Boston Scientific priced $3.0 billion of senior notes in four fixed-rate tranches (5.375%-5.875%) to help fund the ~$14.5 billion Penumbra acquisition, settling December 1, 2026, with a 101% special mandatory redemption if the deal fails.


Key Events · Financing and Capital Events · BSX

  • USD Notes Priced at $3.0B

    Four fixed-rate tranches: $1.0B 3-year at 5.375%, $750M 5-year at 5.500%, $750M 7-year at 5.750% and $500M 10-year at 5.875%, priced at 99.798 to 99.972.

  • Proceeds Fund Penumbra Cash Consideration

    Net proceeds, together with the concurrent euro notes, short-term borrowings and cash on hand, finance the cash consideration for the ~$14.5 billion Penumbra Acquisition and related fees.

  • Deal-Failure Redemption at 101%

    If the Penumbra Acquisition is not completed by the Special Mandatory Redemption End Date, each series must be redeemed at 101% of principal plus accrued interest.

  • Settlement December 1, 2026

    Trade date November 19, 2026 with T+7 settlement on December 1, 2026; first interest payment June 1, 2027.


Analysis · BSX · Industrial Applications And Services

Boston Scientific has locked in $3.0 billion of USD senior notes at coupons of 5.375% to 5.875%, the dollar leg of the financing for its roughly $14.5 billion Penumbra acquisition. Because the notes carry a special mandatory redemption at 101% of principal if the Penumbra deal is not completed by the stated end date, bondholders are effectively underwriting deal-completion risk rather than pure Boston Scientific credit. For equity holders the takeaway is leverage: this stacks on top of the €4.25 billion of euro notes priced earlier today, and the blended cost of that debt is a real, recurring drag on earnings. Ratings sit at A3/A-/A- with negative outlooks at Moody's and S&P, so the acquisition is already pressuring the credit profile.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BSX was trading at $43.07 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $62.3B. The 52-week trading range was $39.57 to $101.91. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 19, 2026, 4:51 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $43.00
Real-time Price: $43.09 info
Change: +$0.0852 (+0.20%) info
Market Cap: $62.313B info
BSX
Nov 19, 2026, 8:38 AM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $43.36
Real-time Price: $43.09 info
Change: -$0.2748 (-0.63%) info
Market Cap: $62.313B info
BSX
Nov 19, 2026, 6:03 AM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $43.51
Real-time Price: $43.09 info
Change: -$0.4248 (-0.98%) info
Market Cap: $62.313B info
BSX
Nov 02, 2026, 5:54 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.16
Real-time Price: $43.09 info
Change: -$1.07 (-2%) info
Market Cap: $62.313B info
BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $43.09 info
Change: -$1.15 (-3%) info
Market Cap: $62.313B info